UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM S-8

 

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 


 

TREVENA, INC.

(Exact name of registrant as specified in its charter)

 


 

Delaware

 

26-1469215

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

Trevena, Inc.

955 Chesterbrook Blvd., Suite 200

Chesterbrook, Pennsylvania 19087

(Address of Principal Executive Offices) (Zip Code)

 


 

2013 Equity Incentive Plan

(Full title of the plan)

 


 

Maxine Gowen, Ph.D.

President and Chief Executive Officer

Trevena, Inc.

955 Chesterbrook Blvd., Suite 200

Chesterbrook, Pennsylvania 19087

(Name, and Address of Agent For Service)

 

(610) 354-8840

(Telephone number, including area code, of agent for service)

 


 

Copies to:

 

Brent B. Siler, Esq.
Derek O. Colla, Esq.
Cooley LLP
1299 Pennsylvania Ave., NW, Suite 700
Washington, DC 20004
Telephone: (703) 456-8000
Fax: (703) 456-8100

 

John M. Limongelli, Esq.
SVP, General Counsel & Chief Administrative Officer
Trevena, Inc.
955 Chesterbrook Blvd., Suite 200
Chesterbrook, PA 19087
(610) 354-8840

 


 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer o

Accelerated filer x

Non-accelerated filer o

Smaller reporting company o

 

 

(Do not check if a
smaller reporting company)

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  x

 

CALCULATION OF REGISTRATION FEE

 

Title of Securities
to be Registered

 

Amount
to be
Registered (1)

 

Proposed
Maximum
Offering Price
per Share (2)

 

Proposed
Maximum
Aggregate
Offering Price (2)

 

Amount of
Registration Fee

 

Common Stock, par value $0.001 per share

 

2,492,431 shares

 

$

1.74

 

$

4,336,829.94

 

$

539.94

 

(1)         Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Registrant’s Common Stock that become issuable under the Registrant’s 2013 Equity Incentive Plan, as amended (the “2013 EIP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Registrant’s Common Stock.

(2)         Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) promulgated under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are calculated using the average of the high and low prices of the Registrant’s Common Stock as reported on the NASDAQ Global Select Market on January 2, 2018.

 

 

 



 

EXPLANATORY NOTE

 

This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 2,492,431 shares of the Registrant’s Common Stock to be issued pursuant to the pursuant to the annual automatic increase provision set forth in Section 3(a) of the Registrant’s 2013 Equity Incentive Plan, as amended.

 

INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION STATEMENT ON FORM S-8

 

The contents of the Registration Statements on Form S-8 previously filed with the Securities and Exchange Commission on February 4, 2014 (File No. 333-191735), May 14, 2014 (File No. 333-195957), January 23, 2015 (File No. 333-201672), January 11, 2016 (333-208948), and January 4, 2017 (333-215421) are incorporated by reference herein.

 

EXHIBITS

 

Exhibit
Number

 

 

 

 

 

3.1

 

Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the SEC on February 5, 2014)

 

 

 

3.2

 

Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K, filed with the SEC on February 5, 2014)

 

 

 

4.1

 

Specimen stock certificate evidencing shares of Common Stock of the Registrant (incorporated by reference to Exhibit 4.2 to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333- 191643), originally filed with the SEC on October 9, 2013)

 

 

 

5.1#

 

Opinion of Cooley LLP

 

 

 

23.1#

 

Consent of Independent Registered Public Accounting Firm

 

 

 

23.2#

 

Consent of Cooley LLP (included in Exhibit 5.1)

 

 

 

24.1#

 

Power of Attorney (included on the signature page of this Form S-8)

 

 

 

99.1

 

2013 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 99.1 to the Registrant’s Registration Statement on Form S-8, filed with the SEC on May 14, 2014)

 


#                                         Filed herewith.

 

2



 

EXHIBIT INDEX

 

Exhibit
Number

 

 

 

 

 

5.1

 

Opinion of Cooley LLP

 

 

 

23.1

 

Consent of Independent Registered Public Accounting Firm

 

 

 

23.2

 

Consent of Cooley LLP (included in Exhibit 5.1)

 

 

 

24.1

 

Power of Attorney (included on the signature page of this Form S-8)

 

3



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of King of Prussia, Commonwealth of Pennsylvania, on January 8, 2018.

 

 

TREVENA, INC.

 

 

 

 

By:

/s/ John M. Limongelli

 

 

John M. Limongelli

 

 

Sr. Vice President, General Counsel & Chief Administrative Officer

 

4



 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints MAXINE GOWEN, PH.D. and JOHN M. LIMONGELLI, and each or any one of them, his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Maxine Gowen, Ph.D.

 

President, Chief Executive Officer and
Director (Principal Executive Officer)

 

January 8, 2018

Maxine Gowen, Ph.D.

 

 

 

 

 

 

 

/s/ Roberto Cuca

 

Sr. Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)

 

January 8, 2018

Roberto Cuca

 

 

 

 

 

 

 

/s/ Leon O. Moulder, Jr.

 

Chairman of the Board of Directors

 

January 8, 2018

Leon O. Moulder, Jr.

 

 

 

 

 

 

 

/s/ Michael R. Dougherty

 

Director

 

January 8, 2018

Michael R. Dougherty

 

 

 

 

 

 

 

/s/ Adam M. Koppel, M.D., Ph.D.

 

Director

 

January 8, 2018

Adam M. Koppel, M.D., Ph.D.

 

 

 

 

 

 

 

/s/ Julie H. McHugh

 

Director

 

January 8, 2018

Julie H. McHugh

 

 

 

 

 

 

 

/s/ Jake R. Nunn

 

Director

 

January 8, 2018

Jake R. Nunn

 

 

 

 

 

 

 

/s/ Anne M. Phillips, M.D.

 

Director

 

January 8, 2018

Anne M. Phillips, M.D.

 

 

 

 

 

 

 

/s/ Barbara Yanni

 

Director

 

January 8, 2018

Barbara Yanni

 

 

 

5